Hypersomnia

Hypersomnia is an excess of sleep paired with daytime sedation that the additional rest does not fully relieve. In harm-reduction contexts the term most commonly names a recognised phase of stimulant withdrawal: the rebound effect that follows when amphetamines, cocaine, methamphetamine, or similar compounds are stopped or sharply reduced after sustained use.

The mechanism reflects two overlapping deficits converging. Stimulants suppress normal sleep architecture — total sleep time, slow-wave sleep, and REM cycles are all compressed during active use. When the substance is removed, the accumulated sleep pressure discharges, sometimes across many days. At the same time, the brain's arousal systems — held at elevated output by the drug — recalibrate downward, and wakefulness feels muted even during hours spent awake.

How it is done

The hypersomnic phase of stimulant withdrawal typically begins within one to several days of the last dose and peaks before gradually resolving over days to weeks. Sleep episodes extend well past what the person would consider normal, and waking hours carry fatigue, cognitive slowing, and difficulty sustaining attention.

Hypersomnia in this context does not arrive alone. It co-occurs with dysphoric mood, reduced motivation, flattened pleasure response, and appetite enhancement — collectively the recognised stimulant withdrawal syndrome. Duration varies with the substance, with the length and intensity of prior use, with whether cessation was abrupt or graduated, and with individual neurobiology.

What it cannot tell you

Hypersomnia's presence does not establish its own cause. Prolonged drowsiness following stimulant cessation may reflect withdrawal rebound, but it may also be uncovering a pre-existing sleep disorder the substance was masking, or it may involve other substances or medical conditions acting in parallel.

The symptom does not indicate how much longer the withdrawal phase will last, nor does it distinguish how much of the sleepiness comes from neurochemical rebound versus sleep-debt repayment. Both contribute; the proportions vary by substance and individual, and the two debts resolve on different timescales.

A resolved hypersomnic phase does not mean withdrawal is complete. Mood disturbance, reduced motivation, and blunted pleasure often persist for weeks after sleep normalises. This period of low reward sensitivity carries its own risk of return to use — distinct from the initial physical rebound, and often less visible to the person experiencing it.